Twenty years of RNA research and diagnostic development… What have we learnt?
Our understanding of the molecular drivers of disease has grown exponentially over the past two decades, largely due to continuous advancements in sequencing technology. DNA mutations, copy number variations, translocations, and fusions have been extensively profiled and have largely dominated the biomarker discovery field. Read our latest article published in Journal Precision Medicine to further delve into what we have learnt from RNA Research and Diagnostic Development.View Resource
Your global partner for biomarker discovery, development & commercialisation.
We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.
Clinical Trial Assays
Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.
A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialisation services.